14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARIA
Delisted

ARIAD Pharmaceuticals Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Mar 13, 2017

Range Low Price High Price Comment
30 days $23.87 $23.99 Monday, 13th Mar 2017 ARIA stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $11.69 $23.99
52 weeks $6.02 $23.99

Historical ARIAD Pharmaceuticals prices

Date Open High Low Close Volume
Oct 17, 2016 $11.14 $11.66 $10.77 $11.12 10 672 300
Oct 14, 2016 $13.15 $13.32 $11.06 $11.14 19 778 600
Oct 13, 2016 $12.80 $13.20 $12.63 $13.07 5 879 000
Oct 12, 2016 $13.57 $13.72 $12.79 $12.80 6 001 000
Oct 11, 2016 $14.06 $14.12 $13.55 $13.64 5 028 100
Oct 10, 2016 $13.75 $14.34 $13.64 $14.19 6 332 200
Oct 07, 2016 $13.34 $13.54 $13.19 $13.40 4 037 100
Oct 06, 2016 $13.80 $14.18 $13.25 $13.35 9 527 100
Oct 05, 2016 $13.64 $13.98 $13.41 $13.87 5 060 400
Oct 04, 2016 $13.60 $13.67 $13.21 $13.36 5 226 100
Oct 03, 2016 $13.62 $13.70 $13.32 $13.59 3 888 400
Sep 30, 2016 $13.76 $13.82 $12.95 $13.69 9 291 000
Sep 29, 2016 $14.03 $14.15 $13.57 $13.71 5 323 600
Sep 28, 2016 $14.15 $14.26 $13.83 $14.14 5 988 900
Sep 27, 2016 $14.14 $14.25 $13.79 $13.95 6 869 100
Sep 26, 2016 $13.75 $14.01 $13.61 $13.96 6 325 700
Sep 23, 2016 $13.57 $13.94 $13.50 $13.52 6 726 000
Sep 22, 2016 $13.50 $13.74 $13.23 $13.63 9 314 700
Sep 21, 2016 $13.30 $13.45 $12.83 $13.41 11 434 000
Sep 20, 2016 $12.19 $13.05 $12.13 $12.90 12 725 500
Sep 19, 2016 $12.15 $12.20 $11.94 $12.11 7 562 400
Sep 16, 2016 $11.61 $12.13 $11.55 $12.12 10 641 400
Sep 15, 2016 $11.29 $11.79 $11.08 $11.70 6 404 400
Sep 14, 2016 $10.68 $11.29 $10.67 $11.01 9 707 100
Sep 13, 2016 $10.32 $10.74 $10.32 $10.64 5 425 200
Click to get the best stock tips daily for free!

About ARIAD Pharmaceuticals

ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of drugs for cancer patients in the United States and internationally. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, the European Union, Australia, Switzerland... ARIA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT